FDA approved Remdesivir for infants without evidence of safety and efficacy.

"The U.S. Food and Drug Administration on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants 4 weeks and older, despite having no evidence the treatment is effective or even safe for young children."

https://childrenshealthdefense.org/defender/fda-remdesivir-infants-safety-efficacy/?eType=EmailBlastContent&eId=cbe39194-1682-4b3b-bf94-5323a131b06f

"In the end, the FDA’s approval of remdesivir is not an assurance of the drug’s safety and efficacy but an indication the agency is no longer interested in protecting the public from potentially harmful and ineffective therapies — or, in other words, in doing its job."

Comments

Popular posts from this blog

Globalists: Canada-US relationships is over – 'It's official! Mark Carney's lost it. This guy is a lunatic.'